Boston Scientific (BSX) Crossed Above the 200-Day Moving Average: What That Means for Investors

23.10.25 15:30 Uhr

Werte in diesem Artikel
Aktien

89,00 EUR -1,60 EUR -1,77%

Indizes

6.738,4 PKT 39,0 PKT 0,58%

After reaching an important support level, Boston Scientific (BSX) could be a good stock pick from a technical perspective. BSX surpassed resistance at the 200-day moving average, suggesting a long-term bullish trend.The 200-day simple moving average helps traders and analysts determine overall long-term market trends for stocks, commodities, indexes, and other financial instruments. The indicator moves higher or lower along with longer-term price moves, serving as a support or resistance level.BSX could be on the verge of another rally after moving 5.9% higher over the last four weeks. Plus, the company is currently a Zacks Rank #2 (Buy) stock.The bullish case solidifies once investors consider BSX's positive earnings estimate revisions. No estimate has gone lower in the past two months for the current fiscal year, compared to 3 higher, while the consensus estimate has increased too.With a winning combination of earnings estimate revisions and hitting a key technical level, investors should keep their eye on BSX for more gains in the near future.Radical New Technology Could Hand Investors Huge GainsQuantum Computing is the next technological revolution, and it could be even more advanced than AI.While some believed the technology was years away, it is already present and moving fast. Large hyperscalers, such as Microsoft, Google, Amazon, Oracle, and even Meta and Tesla, are scrambling to integrate quantum computing into their infrastructure.Senior Stock Strategist Kevin Cook reveals 7 carefully selected stocks poised to dominate the quantum computing landscape in his report, Beyond AI: The Quantum Leap in Computing Power.Kevin was among the early experts who recognized NVIDIA's enormous potential back in 2016. Now, he has keyed in on what could be "the next big thing" in quantum computing supremacy. Today, you have a rare chance to position your portfolio at the forefront of this opportunity.See Top Quantum Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Boston Scientific Corporation (BSX): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Boston Scientific und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf Boston Scientific

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Boston Scientific

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Boston Scientific Corp.

Wer­bung

Analysen zu Boston Scientific Corp.

DatumRatingAnalyst
03.09.2019Boston Scientific OverweightBarclays Capital
16.10.2018Boston Scientific OverweightBarclays Capital
07.09.2018Boston Scientific Strong BuyNeedham & Company, LLC
06.07.2018Boston Scientific Strong BuyNeedham & Company, LLC
26.04.2018Boston Scientific Strong BuyNeedham & Company, LLC
DatumRatingAnalyst
03.09.2019Boston Scientific OverweightBarclays Capital
16.10.2018Boston Scientific OverweightBarclays Capital
07.09.2018Boston Scientific Strong BuyNeedham & Company, LLC
06.07.2018Boston Scientific Strong BuyNeedham & Company, LLC
26.04.2018Boston Scientific Strong BuyNeedham & Company, LLC
DatumRatingAnalyst
28.04.2016Boston Scientific NeutralWedbush Morgan Securities Inc.
04.05.2015Boston Scientific HoldDeutsche Bank AG
05.02.2015Boston Scientific HoldDeutsche Bank AG
30.09.2014Boston Scientific HoldNeedham & Company, LLC
07.01.2013Boston Scientific haltenDeutsche Bank Securities
DatumRatingAnalyst
13.04.2010Boston Scientific "sell"Goldman Sachs Group Inc.
17.03.2010Boston Scientific DowngradeGoldman Sachs Group Inc.
10.10.2008Boston Scientific below averageCaris & Company, Inc.
02.10.2008Boston Scientific DowngradeMerrill Lynch & Co., Inc.
13.12.2007Boston Scientific underperformFriedman, Billings Ramsey & Co

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Boston Scientific Corp. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen